Clinical Chemistry, Vol 34, 1505-1505, Copyright © 1988 by the American Association for Clinical Chemistry

Corrections

Vol. 33:

p 3A, No. 10: A. W. Jones' name should appear before that of G. Simpson on the contents page.

p 2004: In the abstract, 13th line, "washing" should read "ashing."

p 2005: In the equation "10²" should read "10^-2," in both places.

p 2299: The first sentence of the last paragraph on this page should read: "The effect of competitive (uracil) and noncompetitive (NaF) inhibitors of the pyrimidine catabolic pathway on radiolabeled 5-FU breakdown was also evaluated in experiments done at room temperature in plasma and whole blood. NaF had little effect..."

Index: The special report of the Task Force on Cyclosporine Monitoring (pp 1269-88) dosenot appear in the annual index under Cyclosporine and Monitoring therapy, as it should.

Vol. 34:

pp 45, 46: In Tables 1 and 2, the correct unit designation in µg/dL, not mg/L.

p 793: The last sentence in the next to last paragraph (middle column) should conclude: "[for patients] given lowcitrate-content drinks (500 mg/day), their oxalate excretion decreased to normal rates (7)."

The following articles in journals at HighWire Press have cited this article:

				J. H. Riley Clinical Pathology: Preanalytical Variation in Preclinical Safety Assessment Studies-Effect on Predictive Value of Analyte Tests Toxicol Pathol, January 1, 1992; 20(3-2): 490 - 500. [Abstract] [PDF]